{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:09:52Z","timestamp":1790424592670,"version":"4.1.0"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>PURPOSE: Cyclophosphamide (CYP) is an antineoplastic agent used for the treatment of many neoplastic and inflammatory diseases. Hemorrhagic cystitis is a frequent side effect of CYP. Several studies show that simvastatin has important pleiotropic (anti-inflammatory and immunomodulatory) effects. The purpose of the study was to investigate the effect of simvastatin on bladder, ureter and kidney injury caused by CYP. METHODS: Adult male Wistar rats were randomly divided into three groups. The CYP\/SIM group received simvastatin microemulsion by gavage during 7 days (10 mg\/kg body wt) before the administration of CYP and the CYP\/SAL group rats received saline 0.9%. The control rats were not treated. After that, all rats were treated with a single dose of CYP 200 mg\/kg body wt intraperitoneally. The rats were killed 24 h after CYP administration. Plasma cytokines (TNF-\u03b1, IL-1\u03b2, IL-6) were measured by ELISA. Macro and light microscopic study was performed in the bladder, kidney and ureter. RESULTS: In the bladders of CYP\/SIMV treated rats edema of lamina propria with epithelial and sub-epithelial hemorrhage were lower than in CYP\/SAL treated rats. The scores for macroscopic and microscopic evaluation of bladder and ureter were significantly lower in CYP\/SIMV rats than in CYP\/SAL rats. The kidney was not affected. The expression of TNF-\u03b1, IL-1\u03b2 and IL-6 was significatly lower in CF\/SINV rats (164.8\u00b122, 44.8\u00b18 and 52.4\u00b113) than in CF\/SAL rats (378.5\u00b166, 122.9\u00b126 e 123.6\u00b118), respectively. CONCLUSION: The results of the current study suggest that simvastatin pretreatment attenuated CYP-induced urotelium inflammation and decreased the activities of cytokines.<\/jats:p>","DOI":"10.1590\/s0102-86502010000100011","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T09:47:27Z","timestamp":1264672047000},"page":"43-46","source":"Crossref","is-referenced-by-count":31,"title":["Protective effect of simvastatin in the cyclophosphamide-induced hemohrragic cystitis in rats"],"prefix":"10.1590","volume":"25","author":[{"given":"Anna Carolina Batista","family":"Dantas","sequence":"first","affiliation":[{"name":"UFRN,, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco F\u00e1bio de Ara\u00fajo","family":"Batista-J\u00fanior","sequence":"additional","affiliation":[{"name":"UFRN,, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Freitas","family":"Macedo","sequence":"additional","affiliation":[{"name":"UFRN,, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Noronha Castro","family":"Mendes","sequence":"additional","affiliation":[{"name":"UFRN,, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdtalo Medeiros","family":"Azevedo","sequence":"additional","affiliation":[{"name":"UFRN,, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Cunha","family":"Medeiros","sequence":"additional","affiliation":[{"name":"UFRN,, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2005.12.006","article-title":"Statin safety: An overview and assessment of the data-2005","volume":"97","author":"Bays H","year":"2006","journal-title":"Am J Cardiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1185\/030079906X80521","article-title":"The effect of simvastatin on triglyceride-rich lipoproteins in patients with type 2 diabetic dyslipidemia: a silhouette trial sub-study","volume":"22","author":"Miller M","year":"2006","journal-title":"Curr Med Res Opin","ISSN":"https:\/\/id.crossref.org\/issn\/0300-7995","issn-type":"print"},{"key":"ref3","first-page":"2024","article-title":"Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis","volume":"29","author":"Kanda H","year":"2002","journal-title":"J Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0315-162X","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/14737175.5.2.211","article-title":"Treatment with statins in the acute phase of ischemic stroke","volume":"5","author":"Montaner J","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.RES.0000202706.70992.95","article-title":"Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway","volume":"98","author":"Paumelle R","year":"2006","journal-title":"Circ Res","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7330","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0102-86502007000700012","article-title":"Simvastatin improves the healing of infected skin wounds of rats","volume":"22","author":"Rego AC","year":"2007","journal-title":"Acta Cir Bras"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/S0102-86502006001000003","article-title":"Effects of simvastatin in abdominal sepsis in rats","volume":"21","author":"Souza Neto JL","year":"2006","journal-title":"Acta Cir Bras"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical applications","volume":"5","author":"Colvin OM","year":"1999","journal-title":"Curr Pharm Des"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"R574","DOI":"10.1152\/ajpregu.00465.2002","article-title":"COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat","volume":"284","author":"Hu VY","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0022-5347(05)65134-8","article-title":"Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice","volume":"167","author":"Ribeiro RA","year":"2002","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0090-4295(01)01007-X","article-title":"Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine","volume":"58","author":"Eichel L","year":"2001","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.0000080895.05158.8B","article-title":"Statins promote potent systemic antioxidant effects through specific inflammatory pathways","volume":"108","author":"Shishehbor MH","year":"2003","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-5347(17)44929-9","article-title":"Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy","volume":"136","author":"Gray KJ","year":"1986","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-4347(01)00279-1","article-title":"Cyclophosphamide and related anticancer drugs","volume":"764","author":"Baumann F","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl","ISSN":"https:\/\/id.crossref.org\/issn\/1387-2273","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.20403","article-title":"Cyclophosphamide-induced hemorrhagic cystitis successfully treated with conjugated estrogens","volume":"80","author":"Kopterides P","year":"2005","journal-title":"Am J Hematol","ISSN":"https:\/\/id.crossref.org\/issn\/0361-8609","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.ju.0000143192.68223.f7","article-title":"Te A: Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis","volume":"73","author":"Gonzalez RR","year":"2005","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.urology.2006.04.033","article-title":"Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis","volume":"68","author":"Lamale LM","year":"2006","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0022-5347(17)32594-6","article-title":"Interleukin-6 and interstitial cystitis","volume":"152","author":"Lotz M","year":"1994","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0022-5347(05)65005-7","article-title":"A comparison of multiple urine markers for interstitial cystitis","volume":"167","author":"Erickson DR","year":"2002","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000012062","article-title":"Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients","volume":"57","author":"Ballen KK","year":"1999","journal-title":"Oncology","ISSN":"https:\/\/id.crossref.org\/issn\/0030-2414","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-509X.25769","article-title":"Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide: induced hemorrhagic cystitis in rats","volume":"43","author":"Kanat O","year":"2006","journal-title":"Indian J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0019-509X","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.0000080895.05158.8B","article-title":"Statins promote potent systemic antioxidant effects through specific inflammatory pathways","volume":"108","author":"Shishehbor MH","year":"2003","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosissup.2006.01.005","article-title":"Statins: potential new indications in inflammatory conditions","volume":"7","author":"Endres M","year":"2006","journal-title":"Atheroscler Suppl"},{"key":"ref24","first-page":"567","article-title":"The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation","volume":"3","author":"Gelosa P","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/labinvest.3780115","article-title":"Inhibition of monocyte chemotactic protein-1 synthesis by statins","volume":"80","author":"Romano M","year":"2000","journal-title":"Lab Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0023-6837","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cccn.2004.10.007","article-title":"Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein","volume":"353","author":"Wang HR","year":"2005","journal-title":"Clin Chim Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"}],"container-title":["Acta Cirurgica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/acb\/v25n1\/11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T20:15:25Z","timestamp":1685391325000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502010000100011&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0102-86502010000100011"],"URL":"https:\/\/doi.org\/10.1590\/s0102-86502010000100011","relation":{},"ISSN":["0102-8650"],"issn-type":[{"value":"0102-8650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}